Skip to main content
. 2014 Jan 31;9(1):e87993. doi: 10.1371/journal.pone.0087993

Table 3. HSV-2 seroprevalence by HIV seroprevalence and by gender among never-injecting drug users, New York City, 1995–1999 and 2005–2011.

1995–1999 2005–2011
n+/N (%) n+/N (%)
HIV negatives total 91/159 (57)# 857/1527 (56)#
HIV negative males 30/79 (38)* 572/1183 (48)*
HIV negative females 61/80 (76)* 285/344 (83)*
HIV positives total 30/37 (81)# 190/237 (80)#
HIV positive males 11/17 (65)* 99/144 (67)*
HIV positive females 19/20 (95)* 91/93 (98)*
*

Significant differences for males vs. females by chi-square test.

#

Significant differences for HIV seropositives vs. HIV seronegatives by chi-square test.